Lack of focus in the area of expertise of any organization can lead to serious detriments in force or efficiency.
NBCD is dedicated to clinical drug development in Osteoarthritis. We specialize in design and execution of clinical trials within both pain and DMOAD compounds for osteoarthritis. We are experts in placebo response mitigation and selecting the right patients. Our background makes us experts in precision medicine using unique biomarker technologies. We support our biotech and pharmaceutical clients advance their osteoarthritis compounds through all clinical development phases.
We leverage our exceptional network of academic research partners, advisors and dedicated clinical research sites.
We operate in the front-line of clinical and basic research of this disease, and we are dedicated to making a true difference for the patients suffering from this debilitating disease.